secwatch / observer
8-K filed May 20, 2025, 7:59 PM ET ticker VOR CIK 0001817229
leadership confidence high sentiment neutral materiality 0.50

Vor Biopharma CEO Robert Ang designated Principal Financial Officer and Principal Accounting Officer

Vor Biopharma Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert Ang

Principal Financial Officer and Principal Accounting Officer
VOR · Vor Biopharma Inc.
Effective
2025-05-19
Filed
May 20, 2025, 7:59 PM ET
On May 19, 2024, the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) designated Robert Ang, M.B.B.S., M.B.A., the Company’s President and Chief Executive Officer and a director of the Company, as the Company’s principal financial officer and principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Ang changed role as Principal Financial Officer and Principal Accounting Officer at Vor Biopharma Inc..

Action
designated
Role
Principal Financial Officer and Principal Accounting Officer
Exact text from the filing
On May 19, 2024, the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) designated Robert Ang, M.B.B.S., M.B.A., the Company’s President and Chief Executive Officer and a director of the Company, as the Company’s principal financial officer and principal accounting officer.
View on SEC.gov

Vor Biopharma Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-123141
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.